These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11123497)

  • 21. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats.
    Morimoto K; Iwakura Y; Nakatani E; Miyazaki M; Tojima H
    J Pharm Pharmacol; 1992 Mar; 44(3):216-8. PubMed ID: 1354726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
    Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of PEGylated salmon calcitonin in nasal mucosa.
    Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
    J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.
    Lee YH; Perry BA; Labruno S; Lee HS; Stern W; Falzone LM; Sinko PJ
    Pharm Res; 1999 Aug; 16(8):1233-9. PubMed ID: 10468025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving oral absorption of Salmon calcitonin by trimyristin lipid nanoparticles.
    Martins S; Silva AC; Ferreira DC; Souto EB
    J Biomed Nanotechnol; 2009 Feb; 5(1):76-83. PubMed ID: 20055109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
    Sang Yoo H; Gwan Park T
    J Pharm Sci; 2004 Feb; 93(2):488-95. PubMed ID: 14705204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of lipid-based formulations for oral delivery of apomorphine and its diester prodrugs.
    Borkar N; Holm R; Yang M; Müllertz A; Mu H
    Int J Pharm; 2016 Nov; 513(1-2):211-217. PubMed ID: 27615708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers.
    Buclin T; Cosma Rochat M; Burckhardt P; Azria M; Attinger M
    J Bone Miner Res; 2002 Aug; 17(8):1478-85. PubMed ID: 12162502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro permeation profile of a local anaesthetic compound from topical formulations with different rheological behaviour--verified by in vivo efficacy data.
    Welin-Berger K; Neelissen J; Bergenståhl B
    Eur J Pharm Sci; 2001 Oct; 14(3):229-36. PubMed ID: 11576828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
    Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
    J Control Release; 2006 Oct; 115(2):183-8. PubMed ID: 16989920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermosensitive drug delivery system of salmon calcitonin: in vitro release, in vivo absorption, bioactivity and therapeutic efficacies.
    Tang Y; Singh J
    Pharm Res; 2010 Feb; 27(2):272-84. PubMed ID: 19998055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights.
    Ryan SM; Frías JM; Wang X; Sayers CT; Haddleton DM; Brayden DJ
    J Control Release; 2011 Jan; 149(2):126-32. PubMed ID: 20946924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral delivery of salmon calcitonin.
    Lee YH; Sinko PJ
    Adv Drug Deliv Rev; 2000 Aug; 42(3):225-38. PubMed ID: 10963837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats.
    Qi X; Wang L; Zhu J
    J Pharm Sci; 2011 Jun; 100(6):2203-11. PubMed ID: 21491444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation of stable W/O/W type multiple emulsion containing water-soluble drugs and in vitro evaluation of its drug-releasing properties].
    Zhang W; Miyakawa T; Uchida T; Goto S
    Yakugaku Zasshi; 1992 Jan; 112(1):73-80. PubMed ID: 1578347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide.
    Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
    Drug Dev Ind Pharm; 2013 Apr; 39(4):520-5. PubMed ID: 22564052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
    Sinswat P; Tengamnuay P
    Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.